Zinc during and in convalescence from diarrhea has no demonstrable effect on subsequent morbidity and anthropometric status among infants <6 mo of age.

Study answer

What this study found

Zinc did not improve subsequent morbidity or growth compared with placebo, and infants receiving zinc had more days of diarrhea. Over 8 weeks of follow-up, there were no significant differences in change in WAZ, LAZ, or WLZ, and morbidity outcomes were also null: diarrhea incidence rate RR = 1.02; days of diarrhea RR = 1.22; any respiratory infection or pneumonia RR = 1.00; pneumonia RR = 1.04. The authors concluded that young infants do not appear to benefit from this short course of zinc, unlike older children.

Study & population

Randomized, placebo-controlled trial in very young infants 1-5 months of age with acute diarrhea enrolled in low-income districts of Addis Ababa, Ethiopia; Karachi, Pakistan; and New Delhi, India.

Intervention

The active regimen was zinc sulfate 10 mg/day as a dispersible oral tablet, given once daily for 14 days during and after an acute diarrhea episode, compared with placebo.

Key limitation

The intervention was brief, with only 14 days of zinc and 8 weeks of follow-up.

View full study detailsView sourceOpen PDF

Original abstract